Skye Bioscience Inc.(SKYE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SKYE Skye Bioscience Inc.

Closed Good Friday 04-17 16:00:00 EDT

1.44

-0.14

-9.18%

盘后1.43

+0.00-0.33%

19:49 EDT

High1.65	Low1.41	Vol587.64K
Open1.58	D1 Closing1.58	Amplitude15.19%
Mkt Cap44.45M	Tradable Cap24.76M	Total Shares30.97M
T/O880.62K	T/O Rate3.41%	Tradable Shares17.26M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"SKYE","market":"US","secType":"STK","nameCN":"Skye Bioscience Inc.","latestPrice":1.435,"timestamp":1744920000000,"preClose":1.58,"halted":0,"volume":587643,"hourTrading":{"tag":"盘后","latestPrice":1.4302,"preClose":1.435,"latestTime":"19:49 EDT","volume":18005,"amount":25981.0148,"timestamp":1744933798614},"delay":0,"floatShares":17255988,"shares":30974558,"eps":-0.73,"marketStatus":"Closed Good Friday","change":-0.145,"latestTime":"04-17 16:00:00 EDT","open":1.58,"high":1.65,"low":1.41,"amount":880622.0549952,"amplitude":0.151899,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.73,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"symbolChange":{"newSymbol":"SKYED","executeDate":"2023-09-08"},"adr":0,"exchange":"NASDAQ","adjPreClose":1.58,"preHourTrading":{"tag":"盘前","latestPrice":1.63,"preClose":1.58,"latestTime":"09:28 EDT","volume":20119,"amount":31150.6359967,"timestamp":1744896506614},"postHourTrading":{"tag":"盘后","latestPrice":1.4302,"preClose":1.435,"latestTime":"19:49 EDT","volume":18005,"amount":25981.0148,"timestamp":1744933798614},"volumeRatio":0.10118670868137031,"impliedVol":2.3324,"impliedVolPercentile":0.7434},"requestUrl":"/m/hq/s/SKYE","defaultTab":"news","newsList":[{"id":"2527425040","title":"BUZZ-U.S. STOCKS ON THE MOVE-Dow, Nike, Coty","url":"https://stock-news.laohu8.com/highlight/detail?id=2527425040","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527425040?lang=en_us&edition=full_marsco","pubTime":"2025-04-16 01:53","pubTimestamp":1744739611,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Dow, Nike, CotyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nL6N3QT0GU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DOW","AUR","COTY","NKE","CMPS","CVX","FLNC","LU1223082519.USD","NEM","ADM","LU0795875086.SGD","AMAT","PEP","FMC","LU2468319806.SGD","XOM","LU1280957306.USD","LU0788108826.HKD","SPNT","PNC","VLO","RDFN","CTVA","CHD","SKYE","CAT","IE00B5949003.HKD","ACI","HXL","IE00BBT3K403.USD","HWM","LU2249611893.SGD","BK4109","HUN","SEDG","JNJ","MP","EOSE","HPE","ALB","LVS","MTVA","HRL","CYTK","BK4108"],"gpt_icon":1},{"id":"2527440976","title":"Skye Bioscience Stock Rises on Preclinical Data for Weight Loss Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2527440976","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527440976?lang=en_us&edition=full_marsco","pubTime":"2025-04-16 00:31","pubTimestamp":1744734660,"startTime":"0","endTime":"0","summary":"Shares of Skye Bioscience rose after the company announced promising preclinical data for a drug combination including its new CB1 antibody nimacimab.The stock was up 60% to $2.09 Tuesday. Shares have lost 84% over the past 12 months.The biotechnology company said nimacimab combined with tirzepatide resulted in greater than 30% weight loss for mice in a diet-induced obesity model over 25 days.Nimacimab alone demonstrated 24% weight loss, comparable with monlunabant and tirzepatide alone, the company said.Chief Executive Punit Dhillon said data supports the company's belief that its antibody approach can provide meaningful efficacy without the risk of unwanted neuropsychiatric side effects that come with small molecule CB1 inhibitors like monlunabant.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"gpt_icon":0},{"id":"2527447547","title":"Crude Oil Moves Lower; Citigroup Posts Upbeat Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2527447547","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527447547?lang=en_us&edition=full_marsco","pubTime":"2025-04-16 00:10","pubTimestamp":1744733440,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/04/44819308/dow-gains-100-points-citigroup-posts-upbeat-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930227.SGD","LU1791807156.HKD","LU0130102774.USD","LU1201861249.SGD","USAW.SI","GOVX","C","LU0128525689.USD","LU2417539215.USD","TQQQ","MNQmain","LU1668664300.SGD","MURA","BK4534","LU0170899867.USD","NQmain","BK4566","BK4023","BK4585","LU2462157665.USD","LU2456880835.USD","USJW.SI","BK4504","QID","LU0162691827.USD","BK4609","SKYE","LU0072461881.USD",".IXIC","LU0648001328.SGD","LU0106831901.USD","LU0320765646.SGD","BK4588","QLD","LU2360032135.SGD","TSYW.SI","PSQ","IE00BSNM7G36.USD","NVIW.SI","BK4116","RZLV","LU2125154935.USD","BK4608","SQQQ","LU0098860793.USD","LU0052756011.USD","SPRB","BK4583","APLD"],"gpt_icon":1},{"id":"2527999442","title":"William Blair Sticks to Their Buy Rating for Skye Bioscience (SKYE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2527999442","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527999442?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 23:45","pubTimestamp":1744731911,"startTime":"0","endTime":"0","summary":"In a report released today, Andy Hsieh from William Blair maintained a Buy rating on Skye Bioscience (SKYE – Research Report). The company’s shares...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-their-buy-rating-for-skye-bioscience-skye?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-their-buy-rating-for-skye-bioscience-skye?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SKYE"],"gpt_icon":0},{"id":"2527416458","title":"BRIEF-Skye Bioscience Demonstrates Over 30% Weight Loss With Nimacimab And Tirzepatide Combination In Preclinical Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2527416458","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527416458?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 20:51","pubTimestamp":1744721470,"startTime":"0","endTime":"0","summary":"BRIEF-Skye Bioscience Demonstrates Over 30% Weight Loss With Nimacimab And Tirzepatide Combination In Preclinical ModelApril 15 (Reuters) - Eli Lilly and Co LLY.N:SKYE BIOSCIENCE DEMONSTRATES OVER 30%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUA5SCWWV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836914.USD","LU1069344957.HKD","SG9999014898.SGD","LU2264538146.SGD","LU1064131342.USD","SGXZ57979304.SGD","SGXZ81514606.USD","LU1232071149.USD","LU0823416689.USD","LU2491050071.SGD","BK4516","IE00B1BXHZ80.USD","SG9999015952.SGD","LU0471298694.HKD","LU0106261372.USD","SKYE","LU2468319806.SGD","LU1623119135.USD","IE00BJT1NW94.SGD","LU1804176565.USD","LU0094547139.USD","SG9999018865.SGD","LU0820561818.USD","LU2361045086.USD","BK4599","BK4007","LU1093756168.USD","LU2552382132.HKD","LU0354030511.USD","LU1989771016.USD","LU0466842654.USD","LU2491049909.HKD","SG9999015986.USD","LU2602419157.SGD","LU0354030438.USD","LU2211815571.USD","LU2324357040.USD","LU1280957306.USD","LU2106854487.HKD","LU2471134523.USD","LU1974910355.USD","LU0708995401.HKD","SG9999015978.USD","LU0385154629.USD","LU2237443465.HKD","LU1093756325.SGD","SG9999001176.USD","LU0061475181.USD","LU1720051017.SGD"],"gpt_icon":1},{"id":"2527139244","title":"BUZZ-Skye Bioscience rises after experimental weight-loss drug shows promise in mice","url":"https://stock-news.laohu8.com/highlight/detail?id=2527139244","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527139244?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 20:20","pubTimestamp":1744719634,"startTime":"0","endTime":"0","summary":"BUZZ-Skye Bioscience rises after experimental weight-loss drug shows promise in mice** Shares of drug developer Skye Bioscience SKYE.O rise 11.5% to $1.46 premarket** Co says its drug candidate, nimacimab, showed 23.5% weight loss in mice, comparable to Eli Lilly's LLY.N popular drug, tirzepatide, sold as Zepbound, and Novo Nordisk's NOVOb.CO experimental drug, monlunabant** SKYE also says nimacimab, when combined with tirzepatide, showed a greater than 30% weight loss** Initial data from SKYE's mid-stage study in obesity is expected in late Q3/early Q4 2025** Up to last close, stock had fallen 53.7% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nL6N3QT0KJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2063271972.USD","LU0456855351.SGD","LU1061106388.HKD","SG9999015952.SGD","BK4599","IE00BK4W5M84.HKD","LU2471134952.CNY","SGXZ51526630.SGD","LU0061475181.USD","LU2237443465.HKD","BK4581","LU2265009873.SGD","LU0943347566.SGD","BK4533","LU1366192091.USD","LU0079474960.USD","BK4139","LU0417517546.SGD","IE0002141913.USD","LU1712237335.SGD","BK4516","LU1917777945.USD","LU2237443978.SGD","IE00BFTCPJ56.SGD","SG9999014914.USD","LU1623119135.USD","SG9999018865.SGD","SKYE","SG9999017495.SGD","LU1551013342.USD","LU1983299246.USD","LU1974910355.USD","IE00BJT1NW94.SGD","LU1069344957.HKD","LU1868836914.USD","LU1280957306.USD","LU1551013425.SGD","LU0820561818.USD","LU1814569148.SGD","SG9999015978.USD","LU2237443382.USD","LU1127390331.HKD","IE00BJJMRZ35.SGD","LU0203202063.USD","SGXZ57979304.SGD","LU0471298777.SGD","IE00BK4W5L77.USD","LU2471134523.USD","BK4588"],"gpt_icon":1},{"id":"2527496764","title":"Skye Bioscience Demonstrates Over 30% Weight Loss With Nimacimab and Tirzepatide Combination in Preclinical Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2527496764","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527496764?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 19:00","pubTimestamp":1744714801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUA5SCWWV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0708995401.HKD","SG9999015986.USD","LU0320765059.SGD","LU0385154629.USD","LU1061106388.HKD","IE00B2B36J28.USD","LU0823416689.USD","SGXZ31699556.SGD","LU1868837136.USD","SGXZ99366536.SGD","LU2552382215.SGD","LU0456855351.SGD","LU2237443978.SGD","BK4139","SG9999015952.SGD","LU0882574139.USD","SG9999018865.SGD","LU1548497426.USD","LU2461242641.AUD","SKYE","LU0820561909.HKD","LU0198837287.USD","LU1623119135.USD","SG9999014906.USD","LU0122379950.USD","IE0002141913.USD","LU0058720904.USD","LU0256863811.USD","LU0354030511.USD","LU1814569148.SGD","LU2237438978.USD","BK4585","IE00B4R5TH58.HKD","LU0354030438.USD","LU2361045086.USD","LU0289739699.SGD","LU2324357040.USD","IE00BJJMRZ35.SGD","LLY","IE00BJLML261.HKD","LU2750360997.AUD","LU2089984988.USD","LU2112291526.USD","SG9999014898.SGD","LU2237443622.USD","IE00BK4W5M84.HKD","IE00B1BXHZ80.USD","LU1551013425.SGD","LU0471298777.SGD","LU1267930730.SGD"],"gpt_icon":0},{"id":"2527449966","title":"Skye Bioscience Inc - Nimacimab Phase 2a Top-Line Data Expected Late Q3/Early Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2527449966","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527449966?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 19:00","pubTimestamp":1744714801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUA5SCWWV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0256863811.USD","LU2264538146.SGD","LU1023059063.AUD","LU1267930730.SGD","LU2361045086.USD","LU0466842654.USD","BK4533","LU1064131342.USD","SG9999015952.SGD","LU1061106388.HKD","LU1868837300.USD","IE0002141913.USD","LU2491050071.SGD","LU0823416689.USD","LU1232071149.USD","LU2361044949.HKD","IE0004445239.USD","SKYE","LLY","LU2552382132.HKD","LU0456855351.SGD","LU2750360997.AUD","LU2237443382.USD","LU1814569148.SGD","LU2750360641.GBP","SG9999014898.SGD","SG9999001176.SGD","LU0238689110.USD","LU0689472784.USD","LU0097036916.USD","LU1548497426.USD","LU1720051017.SGD","LU2360106947.USD","LU0094547139.USD","LU1069344957.HKD","SG9999014906.USD","SG9999018865.SGD","LU2471134796.USD","BK4588","LU1804176565.USD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU0114720955.EUR","SGXZ57979304.SGD","IE00BJLML261.HKD","LU1868836914.USD","IE00B1BXHZ80.USD","LU1551013342.USD","LU2552382058.USD","BK4585"],"gpt_icon":0},{"id":"2527249965","title":"Skye Bioscience Inc - Nimacimab Shows Additive Weight Loss Effect With Tirzepatide in Dio Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2527249965","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527249965?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 19:00","pubTimestamp":1744714801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUA5SCWWV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1720051017.SGD","LU0097036916.USD","LU0466842654.USD","SKYE","LU2750360641.GBP","IE0004445239.USD","LU1814569148.SGD","LU1023059063.AUD","SG9999001176.SGD","IE00B1BXHZ80.USD","LU0823416689.USD","SGXZ57979304.SGD","LU1868837300.USD","LU0114720955.EUR","LU2552382132.HKD","LU1551013342.USD","LU0689472784.USD","LU1093756325.SGD","LU1267930730.SGD","LU2361044949.HKD","LU2264538146.SGD","LU0256863811.USD","LU2750360997.AUD","IE0002141913.USD","BK4585","LU1061106388.HKD","LU0238689110.USD","LU2552382058.USD","SG9999014898.SGD","LU0456855351.SGD","LU1804176565.USD","BK4588","LLY","LU2491050071.SGD","SG9999018865.SGD","IE00BJJMRZ35.SGD","SG9999015952.SGD","LU1548497426.USD","LU1069344957.HKD","IE00BJLML261.HKD","LU1232071149.USD","LU0094547139.USD","LU2361045086.USD","LU2237443382.USD","SG9999014906.USD","LU1064131342.USD","BK4533","LU2360106947.USD","LU1868836914.USD","LU2471134796.USD"],"gpt_icon":0},{"id":"2527994734","title":"Skye Bioscience Demonstrates Over 30% Weight Loss with Nimacimab and Tirzepatide Combination in Preclinical Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2527994734","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527994734?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 19:00","pubTimestamp":1744714800,"startTime":"0","endTime":"0","summary":"Nimacimab shows comparable weight loss to monlunabant and tirzepatide alone, and an additive effect in combination with tirzepatide, in diet-induced obesity model. “Skye believes nimacimab shows potential both as a monotherapy and in combination with a GLP-1 targeted drug to address unmet needs in obesity with the potential to change weight loss standards of care. Initial data from Skye’s Phase 2a study in obesity is expected in late Q3/early Q4 2025.”Skye also shared new in vitro potency data demonstrating that nimacimab’s non-competitive allosteric binding to CB1 provides for a differentiated and potentially advantageous mechanism of inhibition versus small molecules like monlunabant, which must compete with CB1 agonists. In this study, potency of nimacimab and monlunabant were assessed against two concentrations of the CB1 agonist CP55940. The first condition evaluated potency of e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/skye-bioscience-demonstrates-over-30-110000609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","SKYE"],"gpt_icon":0},{"id":"2527158949","title":"Skye Bioscience to Conduct Meetings at Piper Sandler Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2527158949","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527158949?lang=en_us&edition=full_marsco","pubTime":"2025-04-14 19:00","pubTimestamp":1744628400,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April 14, 2025  -- Skye Bioscience, Inc.  , a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that its executive team will be available for 1x1 meetings at the Piper Sandler Spring Biopharma Symposium on April 17th in Boston, MA.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/skye-bioscience-conduct-meetings-piper-110000635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SKYE","BK4139"],"gpt_icon":0},{"id":"2521237218","title":"Skye Bioscience Is Maintained at Buy by Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2521237218","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521237218?lang=en_us&edition=full_marsco","pubTime":"2025-03-22 01:12","pubTimestamp":1742577120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SKYE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 21, 2025 13:12 ET (17:12 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE"],"gpt_icon":0},{"id":"2521226234","title":"Skye Bioscience Price Target Maintained With a $15.00/Share by Citizens Capital Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2521226234","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521226234?lang=en_us&edition=full_marsco","pubTime":"2025-03-22 00:27","pubTimestamp":1742574420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SKYE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 21, 2025 12:27 ET (16:27 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE"],"gpt_icon":0},{"id":"2521286580","title":"Skye Bioscience price target lowered to $14 from $18 at Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2521286580","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521286580?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 20:40","pubTimestamp":1742560808,"startTime":"0","endTime":"0","summary":"Craig-Hallum analyst Albert Lowe lowered the firm’s price target on Skye Bioscience (SKYE) to $14 from $18 and keeps a Buy rating on the shares. Th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/skye-bioscience-price-target-lowered-to-14-from-18-at-craig-hallum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/skye-bioscience-price-target-lowered-to-14-from-18-at-craig-hallum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SKYE","BK4139"],"gpt_icon":0},{"id":"2521288263","title":"Skye Bioscience (SKYE) Receives a Buy from Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2521288263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521288263?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 19:57","pubTimestamp":1742558266,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on Skye Bioscience (SKYE – Research Report) yesterday and set a price target of $1...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/skye-bioscience-skye-receives-a-buy-from-cantor-fitzgerald?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/skye-bioscience-skye-receives-a-buy-from-cantor-fitzgerald?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SKYE"],"gpt_icon":0},{"id":"2521494398","title":"Skye Bioscience Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2521494398","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521494398?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 05:01","pubTimestamp":1742504512,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc reports results for the quarter ended December 31 - Earnings SummarySkye Bioscience Inc SKYE.OQ reported a quarterly adjusted loss of 24 cents per share for the quarter ended Decem","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nL8N3Q32DT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE"],"gpt_icon":0},{"id":"2521911044","title":"BRIEF-Skye Bioscience Reports Fourth Quarter And Full Year 2024 Financial Results And Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2521911044","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521911044?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 04:49","pubTimestamp":1742503762,"startTime":"0","endTime":"0","summary":"BRIEF-Skye Bioscience Reports Fourth Quarter And Full Year 2024 Financial Results And Provides Business UpdateMarch 20 (Reuters) - Skye Bioscience Inc SKYE.O:SKYE BIOSCIENCE REPORTS FOURTH QUARTER AND","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUABV7Z7Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"gpt_icon":0},{"id":"2521149647","title":"Skye Bioscience Q4 2024 GAAP EPS $(0.24) Beats $(0.27) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2521149647","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521149647?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 04:10","pubTimestamp":1742501401,"startTime":"0","endTime":"0","summary":"Skye Bioscience (NASDAQ:SKYE) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.27) by 11.11 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44425003/skye-bioscience-q4-2024-gaap-eps-0-24-beats-0-27-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Skye Bioscience Q4 2024 GAAP EPS $(0.24) Beats $(0.27) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE"],"gpt_icon":0},{"id":"2521499315","title":"Skye Bioscience Inc: Cash Runway Projected Through at Least Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2521499315","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521499315?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 04:01","pubTimestamp":1742500861,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUABV7Z7Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SKYE"],"gpt_icon":0},{"id":"2521496311","title":"Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2521496311","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521496311?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 04:01","pubTimestamp":1742500861,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUABV7Z7Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SKYE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.skyebioscience.com","stockEarnings":[{"period":"1week","weight":0.0709},{"period":"1month","weight":-0.3734},{"period":"3month","weight":-0.4605},{"period":"6month","weight":-0.6901},{"period":"1year","weight":-0.9173},{"period":"ytd","weight":-0.4929}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Skye Bioscience, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100 used in the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. It has license agreement with university of Mississippi. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.403768},{"month":2,"riseRate":0.4,"avgChangeRate":0.538593},{"month":3,"riseRate":0.4,"avgChangeRate":-0.146364},{"month":4,"riseRate":0.2,"avgChangeRate":-0.099392},{"month":5,"riseRate":0.75,"avgChangeRate":0.036757},{"month":6,"riseRate":0.5,"avgChangeRate":0.0601},{"month":7,"riseRate":0.5,"avgChangeRate":-0.064553},{"month":8,"riseRate":0.25,"avgChangeRate":-0.091062},{"month":9,"riseRate":0,"avgChangeRate":-0.190391},{"month":10,"riseRate":0.25,"avgChangeRate":-0.155215},{"month":11,"riseRate":0.25,"avgChangeRate":-0.0962},{"month":12,"riseRate":0.25,"avgChangeRate":-0.027341}],"exchange":"NASDAQ","name":"Skye Bioscience Inc.","nameEN":"Skye Bioscience Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Skye Bioscience Inc.(SKYE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Skye Bioscience Inc.(SKYE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Skye Bioscience Inc.,SKYE,Skye Bioscience Inc.股票,Skye Bioscience Inc.股票老虎,Skye Bioscience Inc.股票老虎国际,Skye Bioscience Inc.行情,Skye Bioscience Inc.股票行情,Skye Bioscience Inc.股价,Skye Bioscience Inc.股市,Skye Bioscience Inc.股票价格,Skye Bioscience Inc.股票交易,Skye Bioscience Inc.股票购买,Skye Bioscience Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Skye Bioscience Inc.(SKYE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Skye Bioscience Inc.(SKYE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}